← Back to Search

Epigenetic Regulation of Adipose Tissue Distribution in Obesity (Eiffel 2 Trial)

N/A
Waitlist Available
Led By Steven R Smith, MD
Research Sponsored by Translational Research Institute for Metabolism and Diabetes, Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Eiffel 2 Trial Summary

This trialstudies how men and women store fat differently and looks to improve our understanding of the issue. #fitness #health

Eiffel 2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Epigenetic marks in abdominal vs gluteal subcutaneous adipose tissue and adipocytes

Eiffel 2 Trial Design

3Treatment groups
Active Control
Group I: Group A- Women- Healthy 'pears'Active Control3 Interventions
This group will consist of healthy women with a BMI between 23 and 35 kg/m2 as a waist-to-hip ratio of 0.78 or less.
Group II: Group B- Women- Healthy 'apples'Active Control3 Interventions
The group will consist of healthy women with a BMI between 23 and 35 kg/m2 as a waist-to-hip ratio of 0.85 or more.
Group III: Group C- Men- Healthy 'apples'Active Control3 Interventions
The group will consist of men with a BMI between 23 and 35 kg/m2.

Find a Location

Who is running the clinical trial?

Translational Research Institute for Metabolism and Diabetes, FloridaLead Sponsor
40 Previous Clinical Trials
3,570 Total Patients Enrolled
11 Trials studying Obesity
342 Patients Enrolled for Obesity
AdventHealth Translational Research InstituteLead Sponsor
48 Previous Clinical Trials
20,154 Total Patients Enrolled
11 Trials studying Obesity
342 Patients Enrolled for Obesity
Sanford-Burnham Medical Research InstituteOTHER
8 Previous Clinical Trials
394 Total Patients Enrolled
3 Trials studying Obesity
63 Patients Enrolled for Obesity

Media Library

Group A- Women- Healthy 'pears' Clinical Trial Eligibility Overview. Trial Name: NCT02728635 — N/A
Obesity Research Study Groups: Group A- Women- Healthy 'pears', Group B- Women- Healthy 'apples', Group C- Men- Healthy 'apples'
Obesity Clinical Trial 2023: Group A- Women- Healthy 'pears' Highlights & Side Effects. Trial Name: NCT02728635 — N/A
Group A- Women- Healthy 'pears' 2023 Treatment Timeline for Medical Study. Trial Name: NCT02728635 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the participant selection criteria for this clinical trial inclusive of those aged 40 and above?

"This clinical trial requires that participants be aged 18 to 45. 202 trials were designed for patients younger than the age of consent, whereas 596 studies are structured for those above 65 years old."

Answered by AI

Is enrollment currently available for this clinical trial?

"According to the information hosted on clinicaltrials.gov this trial is no longer actively recruiting. The original posting was made July 1st 2016 and it has been updated most recently November 16th 2022. Despite not accepting participants anymore, there are still 956 other studies taking new patients at present."

Answered by AI

Are there any qualifications that would enable me to participate in this experiment?

"This clinical research is seeking 27 individuals with obesity between 18-45 years old. Mandatory requirements for female participants include being over 9 months postpartum, having a weight within 3 kilograms of their baseline in the last three months and have a BMI that falls between 23-35 kg/m2."

Answered by AI
Recent research and studies
~3 spots leftby Apr 2025